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ABSTRACT
Objective: In South Asia, hypertension is the third highest factor contributing in public health burden of disease and major risk factor for coronary 
artery disease especially in women and old age people. The study was aimed to determine the role of gender and age (20–80 years) on severity of 
hypertension to design an effective schedule for management of hypertension.
Methods: The levels of serum cholesterol, triglycerides (TG), high-density lipoprotein (HDL), low-density lipoproteins (LDL), and blood pressure (BP) 
of 240 hypertensive patients were monitored. Cholesterol, TG, and HDL levels were detected using ERBA Reagent kit of Transasia Bio-medicals LTD 
by CHOD-PAP, glycerol phosphate oxidase trinder End point, and polyvinyl sulfonic and polyethyleneglycol-methyl ether based methods, respectively.
Results: The BP and levels of serum cholesterol, TG and LDL were increased in both the genders after 40 years of age. However, the rise in levels of these 
parameters was more in females in comparison to males. A hypertension management schedule involving (BP)/Cholesterol lowering drugs and lifestyle 
changes for period of 60 days showed that combination drug therapy was more effective than monotherapies of same drugs used at higher dosages.
Conclusion: Hypertensive patients strictly followed the prescribed healthy food and exercise schedule showed improvement in their BP and lipid 
profile even with limited drug intervention.
Keywords: Hypertension, Low-density lipoprotein, Triglycerides, Cholesterol and blood pressure.
INTRODUCTION
Hypertension majorly poses a public health burden of disease in South 
Asia [1,2]. It is responsible for 57% of all stroke deaths and 24% of all 
coronary heart disease (CHD) deaths in India [3]. In comparison to 
the year 2000, the number of adults with hypertension is predicted to 
increase by ∼60% to a total of 1.56 billion by the year 2025 worldwide 
due to sedentary life style and unconventional food habits whereas 
uncontrolled hypertension may ultimately lead to organs damage. 
Hence, uncontrolled hypertension is the major risk factor for coronary 
artery disease and stroke. The WHO rated hypertension as one of the 
most important causes of premature death worldwide [4]. However, 
only about 25.6% of treated patients have awareness regarding 
treatment and control of blood pressure (BP) in multicenter study from 
India [5].
According to the worldwide data, around 20.6% of Indian men and 
20.9% of Indian women were suffering from hypertension in 2005 
which is projected to go up to 22.9 and 23.6 for Indian men and women, 
respectively [6]. Recent studies from India have shown the prevalence 
of hypertension to be 25% in urban and 10% in rural people in India [7]. 
The risk of developing essential hypertension increases with age. The 
older persons are more likely to get high BP. Men are more likely to have 
high BP than women up to age the of 45, and by the age of 65 it’s more 
common in women which may include environmental and hormonal 
factors [5].
Antihypertensive drug therapy is used to control the hypertension. 
Most of these drugs are mainly designed based on the understanding of 
renin-angiotensin aldosterone system. Renin a serine protease protein 
and enzyme secreted by the kidneys that regulate the blood volume and 
arterial vasoconstriction thus, regulates the arterial BP. Renin enzyme 
circulates in the blood and hydrolyzes angiotensinogen (a peptide 
hormone and secreted from the liver) to Angiotensin-I which is further 
cleaved in the lungs by endothelial-bound angiotensin-converting 
enzyme into angiotensin II which is the potent constrictor of all blood 
vessels causing the BP to rise. Angiotensin II also acts on the adrenal 
glands and releases aldosterone, which increase re-absorption of 
sodium and water, leading to raised blood volume and raised BP.
Hence, we studied the level of hypertension in males and females 
of different age groups, evaluated the major factors responsible for 
hypertension and effective therapy for its control.
MATERIALS AND METHODS
The blood samples of 240 patients suffering from hypertension/
hypertension related factors of different age groups of male/females 
were collected from Sharma clinical laboratories and Khalsa diagnostic 
laboratory of Amritsar, Punjab, India. The study was conducted on 
already available biological material obtained from the diagnostic 
laboratories with the written consent from the patients which is 
ethically approved. The study protocol was approved by institutional 
ethics committee.
The data collection questionnaire was well prepared and all variables 
were filled on the data extraction format daily which included name, 
age, height, weight, dietary habits, daily routine, family history, and 
health problems such as cardiovascular diseases and hypertension 
was recorded. The blood/serum of these patients was tested for level 
of cholesterol, triglycerides (TG), high-density lipoprotein (HDL), 
and low-density lipoprotein (LDL) to find their correlation with 
hypertension among different age groups in males and females. The BP 
of each patient was measured 2 times on the right arm using automatic 
electronic device (OMRON HEM-7261). The average of two readings 
was used.
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The detection of cholesterol, TG, HDL, and LDL in serum samples was 
done using kits obtained from Beacon Diagnostics Pvt. Ltd., Navsari, 
Gujrat, India and Trans Asia (ERBA) Bio-Medicals Ltd Mumbai, India. 
All the tests were standardized and automated.
Estimation of cholesterol level in serum
The cholesterol from the blood serum was detected by CHOD-PAP 
Method using Erba Cholesterol Diagnostic Test Kit based method 
(Transasia Bio-medicals LTD) in which 1ml of reagent was added to 
10 ml of the prepared serum and solution was allowed to mix well and 
incubated at 37°C for 5 min. Cholesterol esterase hydrolyses esterifies 
cholesterols to free cholesterol which is oxidized to form hydrogen 
peroxide which further reacts with phenol and 4-amino antipyrine 
form a red colored quinoneimine dye complex measured against Blank 
at 505 nm which is directly proportional to the amount of cholesterol 
present in the sample. The level of cholesterol was estimated 
in mg/dl by using formulae Abs. T/Abs. S×200, where T is test sample, 
Abs is absorbance, and S is sample.
Estimation of TG, HDL, and LDL level in serum
The TG from the blood serum was detected using kit-based method 
(ERBA TG Biochemistry Reagent kit, Transasia Bio-medicals LTD) using 
glycerol phosphate oxidase (GPO) trinder End point method in which 
1 ml of reagent was added to 10 ml of the prepared serum allowed to 
mix well and incubated at 37°C for 5 min. The level of triglyceride was 
detected based on the hydrolysis of TG to glycerol and free fatty acids. 
The glycerol is phosphorylated to glycerol-3-phosphate which is then 
oxidized by GPO to yield hydrogen peroxide. The hydrogen peroxide 
causes oxidative coupling of 4-chlorophenol and 4- aminoantipyrine 
present in the reagents of the kit producing a red colored quinoneimine 
dye complex detected at 500 nm which is directly proportional to the 
concentration of TG in the sample. The level of TG was estimated in 
mg/dl in serum by using formulae, TG (mg/dl) = Abs. T/Abs. S×200.
The estimation of HDL using ERBA HDL direct Reagent kit (Transasia 
Bio-medicals LTD) by modified polyvinyl sulfonic acid and 
polyethyleneglycol-methyl ether based method from the blood was 
detected in which serum (1000 µl) was precipitated using 500 µl of 
precipitating reagent in test tube, mixed well and allowed the reaction 
mixture to stand for 10 min at room temperature. It was centrifuged 
at 4000 RPM for 10 min to obtain a clear supernatant. The 50 µl of 
supernatant, blank, and standard was mixed with 1 ml cholesterol 
working reagent and incubate at 37°C for 10 min. The absorbance 
of these was measured against reagent Blank at 505 nm and HDL 
was calculated as (Abs. of Test/Abs. of Calibrator) × Concentration of 
Standard (25) × Dilution Factor. Based on this, LDL was calculated as 
per following formula LDL (mg/dl) = Total Cholesterol – HDL – (TG/5)
Recovery of patients after drug therapy and change in lifestyle
Eleven patients were selected based upon their high levels of cholesterol 
and TG in their serum. They were orally administrated to drugs such 
as Amlodipine, Atenolol, Telmisartan, Atorvastatin, and Ecosprin for 
2 months as prescribed by their physicians.
In addition, based on the health conditions few changes were planned 
in their lifestyle such as incorporation of light exercise/brisk walking 
and change diet plan inclusion of more fruits, vegetables, whole grains, 
fish, nuts, poultry, low-fat dairy products, oils with omega 3 fatty acids 
and, avoiding sugar-containing beverages, red meat, and sweets. The 
cholesterol, TG and LDL were tested in the serum after two months of 
drug therapy/change in lifestyle of these selected patients to detect any 
improvement in their overall health.
RESULTS AND DISCUSSION
The 240 study subjects of different age groups (20–40, 41–60, and 
61–80 years) with 80 patients in each age group were tested for level 
of cholesterol, TG, HDL, and LDL in their blood/serum to find their 
correlation with hypertension in both males and females (Tables 1 and 2). 
Among these 240 patients, the number of males and females was 120 
each.
In Tables 1 and 2, it was observed that the rise in levels of serum 
cholesterol, TG, LDL, and systolic/diastolic BP was more in case 
of females as compared to males. This unfavorable lipid profile 
and increase in BP must be due to decrease in level of estrogen in 
postmenopausal women and lack of workout and imbalanced diet 
culture as observed in Indian women. Further, with increasing age the 
levels of these parameters exceed the normal range in case of both 
males and females due to atherosclerosis and lack of physical activity 
which is commonly observed in aged persons.
The changes in individual parameter with age of both males and females 
were observed as under:













20–40 48 M 195±8.9 148±7.6 118±8.1 139/85±7.3
32 F 175±7.6 129±9.3 102±7.8 128/80±8.4
41–60 35 M 220±7.3 158±11.1 143±7.3 152/90±11.3
45 F 197±6.9 146±9.3 131±9.3 146/85±7.9
61–80 36 M 241±5.9 162±9.1 152±8.2 159/90±9.3
44 F 267±7.8 178±8.3 169±7.8 164/95±8.6
Total=240 - Normal value≤200 Normal value≤150 Normal value 100–129 Normal value 120/80
TG: Triglycerides, LDL: Low-density lipoprotein, BP: Blood pressure
Table 2: Percentage of patients of different age groups with high levels of serum cholesterol, TG, LDL and systolic BP
Age 
groups (years)
Gender (M/F) Percentage (%) of patients
Cholesterol 
(mg/dL) range
TG (mg/dL) range LDL (mg/dL) range Systolic/diastolic BP (mmHg) 
range
200–299 ≥300 150–199 ≥200 100–150 ≥150 120–150/70–90 ≥150/90
20–40 M 15% 5% 17% 10% 25% 10% 52% 5%
F 10 4 13 1 20 6 38 0
41–60 M 32 6 19 4 28 12 36 20
F 28 4 16 6 32 13 29 15
61–80 M 23 10 22 13 29 15 19 22
F 32 15 38 17 33 18 28 31
TG: Triglycerides, LDL: Low-density lipoprotein, BP: Blood pressure
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Cholesterol level test
It was observed that out of 240 patients the level of cholesterol 
in 96 patients was either below or near the borderline, that is, 
200 mg/dL but their BP (systolic and diastolic) was found slightly 
higher, that is, 130/85 than the normal range of 120/80 (Fig. 1). Among 
these 96 subjects, majority (56 subjects) were belonging to the low age 
group, that is, 20–40 years. Further, as the level of mean cholesterol 
level in patients increased to the ranges of 200–250, 250–300, and 
>300 mg/dL their BP also increased drastically to 145/95, 160/110, 
and 195/120, respectively (Fig. 1).
The assessment of data as per the age groups reveals that among 
80 patients of age group 20–40 years, 70% subjects were having level 
of cholesterol <200 mg/dL, 25% having cholesterol in the range of 
200–299 mg/dL, and only 5% with level >300 mg/dL.
However, in case of next 80 patients with age group range of 41–60 years, 
30% patient showed level of cholesterol <200 mg/dL, 60% patients 
were having cholesterol in the range of 200–299 mg/dL, and 10% with 
level >300 mg/dL.
Further, among 80 patients in the age group of 61–80 years 20% 
patients showed level of cholesterol <200–250 mg/dL whereas 55% 
were having cholesterol in the range of 200–299 mg/dL and around 
25% with level > 300 mg/dL (Fig. 2).
The discussion of cholesterol level in relation to age is important as 
aging-induces changes in cholesterol metabolism [6]. The reports in 
literature show that due to low physical activity there is an increase 
in adipose tissues, and insulin resistance which leads to increased 
BP [7,8]. The specific reason behind rise in serum cholesterol with 
increasing age is decrease in breakdown of cholesterol to bile acids 
due to decreased secretion of growth hormone [9]. The gender related 
analysis of this study showed that between the ages of 20–40 years, 
males have significantly higher cholesterol level than females but 
after the age of 40 years the cholesterol level started increasing in 
women and it surpassed the cholesterol levels of males after the age 
of 60 years (Fig, 2). The difference might be caused by deficiency of 
estrogen levels in postmenopausal women which is mainly associated 
with an unfavorable lipid profile [10]. Hence, the data concluded that 
the level of blood cholesterol and the number of patients suffering from 
hypertension increases with increasing age.
TG level test
The level of TG in the serum of 240 patients was observed using kit-
based method. It was observed that out of 240 patients the level of 
TG in 100 patients was either below or near the borderline, that is, 
≤150 mg/dL but their BP (systolic and diastolic) was much higher, 
that is, 145/95 than the normal range of 120/80 (Fig. 3). Further, 
in rest of the 140 patients the level of TG increased drastically to 
the range of 150–>200 mg/dL with an evident rise in BP in range of 
160/110–195/120 (Fig. 3).
On the other hand, after assessing the data as per the age groups it 
was observed that in the age group of 20–40 years out of 80 (100%) 
subjects 60% have level of TG <150 mg/dL whereas 30% patients were 
residing in the range of 150–199 mg/dL and only 10% having high TG 
level >200 mg/dL.
However, when the age group range of the patients increased to 41–
60 years, out of 80 subjects 55% showed level of TG <150 mg/dL, 
35% patients were residing in the range of 150–199 mg/dL, and 10% 
showed high TG level >200 mg/dL.
Further, in the age group of 61–80 years out of 100 subjects only 10% 
patient have TG <150 mg/dL whereas 60% patients were in the range 
of 150–199 mg/dL and around 30% having high TG level > 200 mg/dL 
(Fig. 4).
Hence, the data conclude that in the age group of 20–40, 41–60, and 
61–80-years overall percentage of patients having level of TG higher 
than 150 mg/dL increased to 40%, 45%, and 90%, respectively. Hence, 
Figs. 3 and 4 shows that with increase in age of the patients, the number 
of patients suffering from hypertension increased due to increase in 
their TG and systolic/diastolic BP levels.
In young adulthood, men tend to have higher triglyceride levels than 
women due to huge differences in their energy requirements and 
Fig. 1: Describing the relation between levels of serum cholesterol 







































Fig. 2: Describing the levels of serum cholesterol (mg/dL) in 
patients
Fig. 3: Describing the relationship between levels of serum 
triglyceride (mg/dL) and systolic/diastolic blood pressure 
(mmHg) of 240 patients
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food habits [12]. This study also showed that in the lower age group 
of 20–40 years out of 10% patients with TG >200 mg/dL, 90% were 
males, and 10% were females. However, in 40–60 years of age out of 
10% patients with high TG levels of >200 mg/dL 60% were males 40% 
were females indicating that level of TG started increasing in females as 
well after 40 years (Fig. 4). This might be due the loss of estrogen with 
menopause which is associated with an increase in abdominal adiposity 
as triglyceride levels increases during the menopausal transition [11]. 
A longitudinal study of the menopausal transition reported an increase 
of 16% in triglyceride values [13]. Thus, women with age higher than 
40 years show higher levels of TG than females of younger age [12]. This 
study also indicated as the age increased above 60 years percentage of 
patients with level of TG> 200 mg/dL increased from 10% to 30% and 
among these numbers of affected female increased as compared to males.
Determination of LDL levels in blood
The blood samples of 240 patients of different age groups were 
collected and tested for their levels of LDL using procedure as described 
above. The level of LDL, along with the other factors such as TG, sodium 
and cholesterol, is also considered as the one of the major factors 
contributes to high BP in patient. LDL is considered as bad cholesterol 
as on oxidation it is responsible for atherosclerosis.
Fig. 5 describes that highest number (152) of patients were observed 
with LDL level in the range of 100–150 mg/dL which is in the normal 
to borderline range. In higher range of LDL levels from 151 to 
>200 mg/dL although the number of patients was comparatively less 
(88) but their BP (systolic and diastolic) was found to be increased up 
to 100/160 mmHg. This might be due to the fact that LDL is considered 
to carry cholesterol to the peripheral tissues where it can deposit and 
increase the BP and may leads to arteriosclerotic heart and peripheral 
vascular disease.
As per the age groups as shown in Fig. 6 out of 80 patients of 20–40 years, 
only 10% patients were having level of LDL higher than 150 mg/dL. 
Among these, 90% were males and 10% were females. Similarly, in the 
age group of 41–60 years, 40% patients were having level of LDL higher 
than 150 mg/dL among these 55% were males and 45% were females. 
In the age group of 61–80 years, the number of overall patients having 
level of LDL higher than 150 mg/dL increases to 60% among these 42% 
were males and 58% were females.
Hence, with increase in age group the percentage of patients having high 
level of LDL increases from 10% to 60% and it was also evident that 
females were more prone to increase in their LDL levels with increasing 
age. In case of young females, the level of estrogens increases HDL and 
on the same time improves hepatic clearance of LDL thus decrease LDL. 
However, in elderly females due to low postmenopausal estrogen level 
a decrease in HDL/LDL ratio can be observed which leads to higher risk 
of atherosclerosis-related disorders in females above 50 years [14].
The age-related studies also suggest that in plasma, levels of LDL-
cholesterol increase with aging and clearance of LDL decreases in 
both humans and rodents which becomes the key factor for the onset 
of atherosclerosis and CHD [14]. This is related to the decreased 
breakdown of cholesterol to bile acids and increased intestinal 
cholesterol absorption as observed in aging rodents [14]. In addition, 
it has been reported that in humans with increasing age from 20 to 
60 years plasma LDL-cholesterol increases by about 40% [15]. The 
conditions get severed when along with LDL other factors such as high 
TG, sodium level also contributes to high BP in patient.
Recovery of patients after drug therapy/change in lifestyle
Eleven (11) hypertensive patients were selected with high levels of 
cholesterol, TG and LDL in their serum and administrated orally to 
drugs such as Amlodipine, Atenolol, Telmisartan, Atorvastatin, and 
Ecosprin for 2 months as a monotherapy and/or in combination therapy 
as prescribed by their doctors. The younger patients belonging to age 
group of 20–40 years were having comparatively low cholesterol but 
high BP so administered to combination of Atenolol and Atorvastatin. 
Atenolol a beta blocker blocks the action of epinephrine and lowers the 
heart rate, BP, and strain on the heart. Atorvastatin raises the level of 
HDL in the blood. This efficiently controlled their BP and cholesterol 
levels within 60 days of treatment (Table 3).
Further, administration of Amlodipine along with Atenolol and 



































Fig. 6: Describing the levels of serum LDL (mg/dL) in patients (%) 
of different age groups
Fig. 5: Describing the relationship between levels of serum LDL 





































Fig. 4: Describing the levels of serum triglyceride (mg/dL) in 
patients (%) of different age groups
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patients of higher age group of 41–60 years. Amlodipine acted as a 
calcium channel blocker and worked by relaxing blood vessels for 
smooth flow of blood. Thus, out of four patients (two males and two 
females), two males showed a drastic decrease in levels of cholesterol, 
TG, LDL, and BP after 60 days in comparison to their respective levels 
before taking medications/management (Table 3). In combination 
therapy, low doses were as effective as high doses of same drugs in 
monotherapies.
However, in even higher age group of 61–80 years a combination therapy 
of telmisartan, amlodipine, and Ecosprin has worked better than Atenolol 
and Atorvastatin as out of 5 patients (two males and three females), 
three females showed an effective control in BP and other recorded lipid 
parameters. In this case, Telmisartan an angiotensin receptor blocker, 
relaxed the blood vessels whereas and Ecosprin an antiplatelet drug 
was used to prevent clots in blood vessels and also relieved pain and 
inflammation which is commonly observed in aged patients [13]. In aged 
patients, monotherapies of these drugs have low efficiency as compared 
to their combination therapy to control hypertension and high dosage 
was required to efficiently normalize the BP. A study with 1461 patients 
revealed, that taking telmisartan 0, 20, 40, and 80 mg and amlodipine 
0, 2.5, 5, and 10 mg for 60 days induces greater BP reductions with 
combination therapy than with respective monotherapies [13].
In addition, changes in their lifestyle and dietary habits were also 
planned such as incorporation of light exercise/brisk walking, inclusion 
of more fruits, vegetables, whole grains, fish, nuts, poultry, low-fat dairy 
products, oils with omega 3 fatty acids and, avoiding sugar-containing 
beverages, red meat, and sweets.
Hence, overall, seven out of 11 patients managed to control the BP 
and other parameters because they were strictly following the above 
prescribed diet and workout plans by their physicians (Table 3). It was 
observed that such patients after certain point of time were able to 
control their BP and lipid levels with comparatively low levels of drug 
dosages and came up with good health and physical parameters (data 
not shown). In the United States, National Harris interactive survey for 
hypertension, disclosed that only 50–60% patients remain involved 
in different kind of lifestyle change to control BP, whereas majority of 
patients rely only on medication to control hypertension [10]. Thus, 
a tight control of BP and lipid profile is required especially in female 
and aged persons to prevent later hypertension and heart related 
complications in life [7,10].
CONCLUSION
The results of this study describe that patient with elevated levels 
of Cholesterol, LDL, and TG more likely to show hypertension with 
increasing age. The rise of these parameters was more significant in 
case of females above 40 years than that of males of same age group. 
This must be due to decreasing level of estrogen in postmenopausal 
women which is further aggravated by aging, lack of workout, and 
imbalanced diet. Hence, the study suggests that females should be more 
careful in monitoring their BP and lipid profile after 40 years.
Second, the study also included the role of drug intervention and 
change in lifestyle/dietary habits to control hypertension and related 
cardiovascular diseases in selected hypertensive patients. It was 
observed that, monotherapies of the selected drugs have low efficiency 
as compared to the combination drug therapy to control hypertension. 
In combination therapy, low doses were found as effective as high doses 
of same drugs in monotherapies. More than 60% of these patients 
showed a significant improvement in their health, BP, and lipid profile.
Third, the data indicated that different types of drug and lifestyle 
changes are required for patients of different age group as same 
schedule may not be effective to control the hypertension and lipid 
profile in all age groups.
Finally, it was observed that those patients who rely only on drug 
therapies were less likely to control their high BP and lipid parameters. 
However, those who changed their food habits and included workout 
regime as prescribed in their lifestyle showed a better improvement in 
their BP and lipid levels.
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